GA2LEN NoE calls for more focus on allergies in FP7

The Network of Excellence (NoE) GA2LEN is urging policy makers to support the European Parliament's proposal to include allergic diseases in the health priorities of the Seventh Framework Programme (FP7).

While allergies are mentioned among the food research priorities in the European Commission's proposal, members of GA2LEN would like to see the wider allergy problem a top priority for health research. Only 8% of allergies in Europe are related to food.

"The absence of the wider allergy problem as a top concern in health research agenda threatens to compromise overall progress in the understanding of this complex condition," says the Network in a statement.

Allergies are a global problem, although the presentation and cause of the reactions vary. Researchers believe that the many different aspects of the condition, as well as its triggers, must be addressed if we are to gain a comprehensive understanding of allergic diseases as a whole.

Allergies can be fatal. According to the World Health Organization (WHO), asthma kills someone in Europe every hour. And the problem is becoming more widespread -one child in three is now allergic to something, and by 2015, half of all Europeans may be suffering from one or more allergic condition.

For sufferers, allergies can have a major impact of daily life. Children with allergic diseases miss days at school and must sometimes abstain from sport and other recreational activities, while breathing and skin problems dent the confidence of children and adults.

GA2LEN also highlights the financial costs of allergies, which estimates suggest amount to €100 billion per year.

The GA2LEN network brings together 26 allergy research centres around Europe with the aim of advancing diagnosis, prevention and treatment of allergic diseases. In recent months, a European database of comparable, longitudinal epidemiological studies, known has cohorts, has been completed. This should help scientists to conduct a more reliable analysis of the multiple genetic and environmental factors causing allergies.

For further information on GA2LEN, please visit:
http://www.ga2len.net

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...